The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Tekmira Pharmaceuticals Corp

TSX: TKM
Delayed quote

$17.41

Today's change-0.76 -4.18%
Updated November 27 3:54 PM EST. Delayed by at least 15 minutes.
 

Tekmira Pharmaceuticals Corp

TSX: TKM
Delayed quote

$17.41

Today's change-0.76 -4.18%
Updated November 27 3:54 PM EST. Delayed by at least 15 minutes.

Tekmira Pharmaceuticals Corp down $0.76

Tekmira Pharmaceuticals Corp closed sharply lower Thursday, dropping $0.76 or 4.18% to $17.41. Shares have lost 4.60% over the last five days, but have gained 106.04% over the last year to date. This security has outperformed the S&P TSX by 93.15% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$1.92
Updated November 27 3:54 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue4247
Total other revenue--------
Total revenue4247
Gross profit--------
Total cost of revenue--------
Total operating expense1111109
Selling / general / administrative2223
Research & development9987
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)------0
Other operating expenses, total--------
Operating income-7-9-6-2
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-9-6-18-2
Income after tax-9-6-18-2
Income tax, total0000
Net income-9-6-18-2
Total adjustments to net income--------
Net income before extra. items-9-6-18-2
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-9-6-18-2
Inc. avail. to common incl. extra. items-9-6-18-2
Diluted net income-9-6-18-2
Dilution adjustment----00
Diluted weighted average shares22222016
Diluted EPS excluding extraordinary itemsvalue per share-0.39-0.28-0.91-0.14
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.39-0.28-0.91-0.14